- Home
- NAC vs NKTR Comparison
NAC vs NKTR Comparison
Compare NAC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAC | NKTR |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | NAC | NKTR |
|---|---|---|
| Price | $11.58 | $72.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $142.00 |
| AVG Volume (30 Days) | 509.7K | ★ 806.5K |
| Earning Date | 01-01-0001 | 03-12-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $307,711,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 86.00 |
| 52 Week Low | $10.35 | $0.43 |
| 52 Week High | $12.25 | $77.00 |
Technical Indicators
Market Signals| Indicator | NAC | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 29.50 | 58.89 |
| Support Level | $11.57 | $52.99 |
| Resistance Level | $11.64 | $75.96 |
| Average True Range (ATR) | 0.08 | 3.73 |
| MACD | -0.03 | -0.75 |
| Stochastic Oscillator | 2.54 | 64.68 |
Price Performance
Historical ComparisonAbout NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.